NCT02242123View on ClinicalTrials.gov

Celiac Disease Diagnosis in Patients With Weakly Positive Serum Anti-Transglutaminase: Duodenal Anti-Endomysium Assay.

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

December 31, 2016

Study Completion Date

June 1, 2020

Conditions

Celiac Disease

Trial Locations (2)

90127

Internal Medicine Department of the University Hospital of Palermo, Palermo

92019

Internal Medicine Department of the Hospital of Sciacca (Agrigento), Sciacca

All Listed Sponsors

lead

University of Palermo

OTHER

NCT02242123 - Celiac Disease Diagnosis in Patients With Weakly Positive Serum Anti-Transglutaminase: Duodenal Anti-Endomysium Assay. | Biotech Hunter | Biotech Hunter